Experimental Hematology And Oncology impact factor, indexing, ranking (2024)


experimental

Aim and Scope

The Experimental Hematology And Oncology is a research journal that publishes research related to Biochemistry, Genetics and Molecular Biology; Medicine. This journal is published by the BioMed Central Ltd.. The ISSN of this journal is 21623619. Based on the Scopus data, the SCImago Journal Rank (SJR) of experimental hematology and oncology is 1.908.

Also, please check the following important details about experimental hematology and oncology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Experimental Hematology And Oncology Ranking

Journal Rank: 1427
SJR (SCImago Journal Rank): 1.908
Quartile: Q1
H-Index: 35

The SJR (SCImago Journal Rank) measures citations weighted by prestige. It is useful for comparing journals within the same field, and forms the basis of the subject category ranking. A journal SJR indicator is a numeric value representing the average number of weighted citations received during a selected year per document published in that journal during the previous three years, as indexed by Scopus. Higher SJR indicator values are meant to indicate greater journal prestige. SJR is developed by the Scimago Lab, originated from a research group at University of Granada. Q1 journals are cited more often and by more prestigious journals than those in the other quartiles.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

CiteScore of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal. This journal evaluation metric was launched in December 2016 by Elsevier as an alternative to the generally used JCR impact factors (calculated by Clarivate). CiteScore is based on the citations recorded in the Scopus database rather than in JCR, and those citations are collected for articles published in the preceding four years instead of two or five.

Source Normalized Impact per Paper (SNIP) is calculated annually from Scopus data. It is a sophisticated metric that intrinsically accounts for field-specific differences in citation practices.



Important Metrics

Journal Title: Experimental Hematology and Oncology
Publisher: BioMed Central Ltd.
ISSN: 21623619
Type: journal
Journal Scope: Biochemistry, Genetics and Molecular Biology; Medicine
Country: United Kingdom
H-Index: 35
SJR: 1.908
Quartile: Cancer Research (Q1); Hematology (Q1); Oncology (Q1)

experimental hematology and oncology Indexing

The experimental hematology and oncology is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Experimental Hematology And Oncology Quartile

The latest Quartile of experimental hematology and oncology is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Experimental Hematology And Oncology?

If your research is related to Biochemistry, Genetics and Molecular Biology; Medicine, then visit the official website of experimental hematology and oncology and send your manuscript.

Tips for publishing in Experimental Hematology And Oncology:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.


Final Summary

  • It is published by BioMed Central Ltd..
  • The journal is indexed in UGC CARE, Scopus.
  • The (SJR) SCImago Journal Rank is 1.908.

Sources: experimental hematology and oncology







SIMILIAR JOURNALS


DNA AND CELL BIOLOGY

ISSN: 1044-5498
Publisher: MARY ANN LIEBERT, INC

JOURNAL OF MOLECULAR EVOLUTION

ISSN: 0022-2844
Publisher: SPRINGER

MOLECULAR BIOLOGY AND EVOLUTION

ISSN: 0737-4038
Publisher: OXFORD UNIV PRESS

MOLECULAR PHYLOGENETICS AND EVOLUTION

ISSN: 1055-7903
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE

ONCOGENE

ISSN: 0950-9232
Publisher: SPRINGERNATURE

MOLECULAR REPRODUCTION AND DEVELOPMENT

ISSN: 1040-452X
Publisher: WILEY

GENE THERAPY

ISSN: 0969-7128
Publisher: SPRINGERNATURE

NON-CODING RNA

ISSN:
Publisher: MDPI

BIOCHEMICAL GENETICS

ISSN: 0006-2928
Publisher: SPRINGER/PLENUM PUBLISHERS

CHROMOSOMA

ISSN: 0009-5915
Publisher: SPRINGER

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.